Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy.
Rac G, Patel HD, James C, Desai S, Caruso VM, Fischer DS, Lentz PS, Ward CT, Mazzarella BC, Phillips KG, Doshi C, Bicocca VT, Levin TG, Wolfe AJ, Gupta GN.
Rac G, et al. Among authors: phillips kg.
Mol Oncol. 2024 Feb;18(2):291-304. doi: 10.1002/1878-0261.13530. Epub 2023 Oct 5.
Mol Oncol. 2024.
PMID: 37753732
Free PMC article.